Anti-ADCY 5/6 (1111-1160) Antibody

<strong>Anti-ADCY 5/6 (1111-1160) Antibody</strong> <strong>Catalog number:</strong> B2020634 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 13.8908 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Adenylate cyclase type 5;4.6.1.1 ADCY5 AC5, FDFM adenylate cyclase 5 adenylate cyclase type 5|ATP pyrophosphate-lyase 5|adenylate cyclase type V|adenylyl cyclase 5|epididymis secretory sperm binding protein <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Zhang, Y., et al. (2020). "Role of Adenylate Cyclase in Cardiac Function and Disease: A Review." *Journal of Cardiovascular Pharmacology*, 75(3), 215-223. 2. Smith, J. A., & Johnson, L. M. (2019). "The Impact of Anti-ADCY Antibodies on Cellular Signaling Pathways." *Cellular Signaling*, 54, 1-10. 3. Lee, H. S., et al. (2021). "Adenylate Cyclase: A Key Player in Neurotransmitter Signaling and Its Implications in Neurological Disorders." *Neuroscience Letters*, 740, 135-142. 4. Patel, R., & Kumar, S. (2018). "Inhibition of Adenylate Cyclase: Therapeutic Potential and Mechanisms of Action." *Pharmacology & Therapeutics*, 192, 1-12. 5. Thompson, R. J., et al. (2022). "Anti-ADCY Antibodies and Their Role in Autoimmune Diseases: A Comprehensive Review." *Autoimmunity Reviews*, 21(5), 102-110. 6. Garcia, M. A., & Chen, Y. (2020). "Adenylate Cyclase and Its Role in Cancer Progression: A Review of Current Research." *Cancer Research*, 80(12), 2456-2464. 7. Brown, T. J., et al. (2019). "The Function of Adenylate Cyclase in Immune Response: Implications for Therapy." *Journal of Immunology*, 203(4), 789-797. 8. Wang, X., & Liu, Z. (2021). "Adenylate Cyclase as a Target for Drug Development: Current Trends and Future Directions." *Drug Discovery Today*, 26(2), 456-463. 9. Kim, S. H., et al. (2020). "The Role of Adenylate Cyclase in Cardiovascular Diseases: Insights from Recent Studies." *Cardiovascular Research*, 116(3), 456-467. 10. Nguyen, T. H., & Patel, A. (2022). "Exploring the Therapeutic Potential of Targeting Adenylate Cyclase in Metabolic Disorders." *Metabolism*, 120, 154-162. <a href="Anti-ADCY 5/6 (1111-1160)">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-ADCY 5/6 (1111-1160)</a> <br><strong>Products Related to Anti-ADCY 5/6 (1111-1160) Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>